248.82USD-1.67%Mkt Cap: 598.96B $P/E: 28.831d ago
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine…
Industry Peers
Drug Manufacturers - General$1.02TUSDP/E 40.7
$449.63BUSDP/E 124.8
$305.65BUSDP/E 21.0
$307.25BUSDP/E 35.1
$274.33BUSDP/E 22.0
$268.08BUSDP/E 21.8
$239.58BUSDP/E 24.9
$250.52BUSDP/E 25.0
$211.34BUSDP/E 12.0
$196.55BUSDP/E 25.4
$165.39BUSDP/E 18.1
$141.06BUSDP/E 18.9
$122.85BUSDP/E 16.9
$100.06BUSDP/E 19.4
$81.94BUSDP/E 13.3
$50.52BUSD
$29.52BUSDP/E 21.5
MRV
Marvell Technology, Inc.$20.75BUSDP/E 7.7
$11.51BUSDP/E 18.0
$11.48BUSDP/E 17.9
$11.35BUSDP/E 22.7
$6.96BUSDP/E 15.4
$3.54BUSDP/E 14.5
$2.97BUSDP/E 18.1
$53.73MUSD
$38.66MUSD
ELXR
Elixxer Ltd.$9.51MUSD
FLXN
Horizon Flexible Income ETF—P/E 26.9
ROSE
DocMorris AG—
FR0000140022
SANOFITP29OCT49—
PHOO
Photocure ASA—
CELG-RI
Bristol-Myers Squibb Company Ce—
Indicators:|
Key Statistics
Company
Market Cap598.96B $
Enterprise Value642.06B $
Revenue (TTM)97.93B $
Gross Profit63.94B $
Net Income (TTM)26.80B $
Revenue/Share40.51 USD
Last Price248.82 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees138.2K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS4781601046
Valuation
P/E (Trailing)28.83
P/E (Forward)19.73
PEG4.18
EV/EBITDA18.43
EV/Revenue6.56
P/S6.22
P/B7.50
EPS (TTM)8.63
EPS (Forward)12.83
52W Range
162.7881% of range269.43
52W High269.43 USD
52W Low162.78 USD
Profitability
Gross Margin67.88%
Oper. Margin28.61%
EBITDA Margin35.58%
Profit Margin28.46%
ROE32.87%
ROA13.46%
Growth
Revenue Growth6.60%
Earnings Growth-1.00%
Cash Flow & Leverage
Operating CF24.53B $
CapEx (TTM)5.22B $
FCF Margin—
FCF Yield—
Net Debt32.94B $
Net Debt/EBITDA0.95
Balance Sheet
Debt/Equity0.59
Current Ratio—
Quick Ratio—
Book Value/Sh33.73 USD
Cash/Share9.160 USD
Dividends
Fwd Div Rate5.360 USD
Trail. Div Rate5.240 USD
Div. Yield2.12%
5Y Avg Yield2.77%
Payout Ratio60.79%
Ex-Div DateAug 25, 2026
Pay DateSep 8, 2026
Splits
Last Split2:1
Split DateJun 13, 2001
Analyst Consensus
Rating1.9 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)269.95 USD
Upside (mean)+8.5%
Target Range190.00 USD – 305.00 USD
$190.00+8.5% to mean$305.00
# Analysts22
Ownership
Shares Out.2.41B
Float2.40B
Insiders0.05%
Institutions76.88%
Short Interest
Short Ratio3.0d
Short % Float1.23%
Short % Out.1.10%
Shares Short26.58M
Short (prev mo.)23.41M
Technical
SMA 50238.66 (+4.3%)
SMA 200222.92 (+11.6%)
Beta0.23
S&P 52W Chg18.27%
Avg Vol (30d)7.13M
Avg Vol (10d)8.15M
Technical Indicators
RSI (14)50.1
MACD3.6748
MACD Signal5.4184
MACD Hist.-1.7436
BB Upper270.62 USD
BB Middle252.85 USD
BB Lower235.07 USD
BB Width14.06%
ATR (14)6.136 USD
Vol Ratio (20d)0.80x